Tang-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
202
Total Value
1807581363
Accession Number
0001214659-25-007882
Form Type
13F-HR
Manager Name
Tang-Capital-Management
Data Enrichment
98% identified
198 identified4 unidentified

Holdings

202 positions
Manager:
Search and click to pin securities to the top
Page 3 of 11
Vaxcyte, Inc.
Shares:300.0K
Value:$11.3M
Keros Therapeutics, Inc.
Shares:1.1M
Value:$11.2M
Teladoc Health, Inc.
Shares:1.4M
Value:$11.1M
Journey Medical Corp
Shares:1.9M
Value:$10.9M
Vanda Pharmaceuticals Inc.
Shares:2.4M
Value:$10.8M
07725L102
Shares:37.0K
Value:$10.1M
ARVINAS, INC.
Shares:1.4M
Value:$9.8M
Harmony Biosciences Holdings, Inc.
Shares:281.2K
Value:$9.3M
Alibaba Group Holding Ltd
Shares:70.0K
Value:$9.3M
CRISPR Therapeutics AG
Shares:266.5K
Value:$9.1M
Moderna, Inc.
Shares:305.3K
Value:$8.7M
Cullinan Therapeutics, Inc.
Shares:1.1M
Value:$8.5M
Elanco Animal Health Inc
Shares:800.1K
Value:$8.4M
PLIANT THERAPEUTICS, INC.
Shares:6.0M
Value:$8.1M
Bausch & Lomb Corp
Shares:550.0K
Value:$8.0M
INSMED Inc
Shares:100.0K
Value:$7.6M
Phathom Pharmaceuticals, Inc.
Shares:1.2M
Value:$7.5M
Apogee Therapeutics, Inc.
Shares:200.0K
Value:$7.5M
HilleVax, Inc.
Shares:4.9M
Value:$7.1M
ImmunityBio, Inc.
Shares:2.3M
Value:$7.0M